CUV 2.80% $13.19 clinuvel pharmaceuticals limited

If the regulators do end up demanding the confirmatory data from...

  1. 648 Posts.
    If the regulators do end up demanding the confirmatory data from the EPP trial before approving, there's not much chance IMO we see this approved in 2010.

    It takes a while just for Clinuvel to collect and analyze the confirmatory data...and this is assuming the spring trial even starts on time.

    I think the current PPS reflects investors' belief that this is all being stretched out even further...again.

 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.